Global Expansion ALRT has pursued international expansion, including Singapore migration and Canadian launch plans, plus a May 2026 GluCurve Pet CGM launch, signaling readiness to scale through international clinics, veterinary networks, and distribution partners for both human and animal diabetes care.

Vet Market Upsell GluCurve Pet CGM rollout expands into veterinary clinics and pet health plans, creating cross selling opportunities to veterinary practices, animal hospitals, and pet insurers seeking CGM solutions that complement the human Health-e-Connect platform.

Remote Care Platform FDA cleared Health-e-Connect enables meter data uploads to a secure clinician portal, positioning ALRT to partner with hospitals and health systems seeking remote monitoring and care coordination that improves adherence and can reduce costs.

Partnership Engine Past and upcoming collaborations with Infinovo, Diabetes Singapore, and Canadian expansion plans illustrate a collaboration driven GTM; opportunities exist for OEM partnerships, distributor agreements, and co developed care platforms with CGM manufacturers and regional networks.

Enterprise Growth With mid market revenue and a lean team, target buyers include mid size hospitals, clinics, and veterinary networks; potential deals with payer programs, health plans, and multi site health systems for GluCurve and Health-e-Connect licensing and services.